Register Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Hold
2,838
0.11% 175
2026
Q1
$396K Hold
2,838
0.15% 140
2025
Q4
$348K Hold
2,838
0.14% 144
2025
Q3
$315K Hold
2,838
0.12% 151
2025
Q2
$315K Sell
2,838
-757
-21% -$80.6K 0.14% 146
2025
Q1
$403K Sell
3,595
-121
-3% -$12.5K 0.21% 110
2024
Q4
$343K Sell
3,716
-450
-11% -$40.5K 0.17% 126
2024
Q3
$349K Hold
4,166
0.18% 123
2024
Q2
$286K Hold
4,166
0.14% 138
2024
Q1
$305K Buy
4,166
+250
+6% +$19.2K 0.16% 129
2023
Q4
$317K Buy
3,916
+566
+17% +$44K 0.21% 115
2023
Q3
$251K Sell
3,350
-505
-13% -$38.8K 0.18% 116
2023
Q2
$297K Sell
3,855
-300
-7% -$23.9K 0.21% 106
2023
Q1
$345K Buy
4,155
+1,100
+36% +$91.1K 0.27% 94
2022
Q4
$262K Buy
+3,055
New +$242K 0.17% 130

Other funds holding GILD

Register Financial Advisors's GILD Position: Q2 2026 in Review

Register Financial Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,838 shares worth $359K. The position accounts for 0.11% of the portfolio, ranked #175.

Register Financial Advisors first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $403K in Q1 2025. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Register Financial Advisors held 2,838 shares of Gilead Sciences worth $359K as of Q2 2026.
  • Register Financial Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.11% of Register Financial Advisors's portfolio in Q2 2026, its #175 holding.
  • Register Financial Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Register Financial Advisors's Gilead Sciences position peaked at $403K in Q1 2025.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Register Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.